Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

14 Jan 2021 07:00

RNS Number : 6269L
Polar Capital Holdings PLC
14 January 2021
 

14 January 2021

 

Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM") and performance fees earned for the calendar year to 31 December 2020.

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 December 2020 its AuM were ÂĢ18.9bn compared to ÂĢ12.2bn at the end of March 2020, an increase of 55% over the period. During the period, AuM increased by ÂĢ6.7bn which comprised net subscriptions of ÂĢ1,462m, inflows from the acquisition of the Phaeacian team of ÂĢ431m, offset by outflows from a previously reported fund closure of ÂĢ301m and an increase of ÂĢ5,237m related to market movement and fund performance.

 

AuM movement in nine months to 31 December 2020

Long-only

funds

Alternative

funds

Total

AuM at 1 April 2020

ÂĢ11,078m

ÂĢ1,083m

ÂĢ12,161m

Net subscriptions/(redemptions)

ÂĢ1,485m

ÂĢ(23)m

ÂĢ1,462m

Acquisition of the Phaeacian team

ÂĢ431m

-

ÂĢ431m

Closure of UK Absolute Equity Fund

-

ÂĢ(301)m

ÂĢ(301)m

Market movement and performance

ÂĢ5,034m

ÂĢ203m

ÂĢ5,237m

Total AuM at 31 December 2020

ÂĢ18,028m

ÂĢ962m

ÂĢ18,990m

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fee profits (after the deduction of staff interests) earned in the first nine months of the Group's financial year.

 

Performance fee profit

net of staff allocations

Nine months to

31 Dec 19

Year to

31 Mar 20

(year-end)

Nine months to

31 Dec 20*

Net performance fee profit

ÂĢ8.8m

ÂĢ8.8m

ÂĢ19.3m*

 

\* The figures to December 2020 are enhanced by what is expected to be circa ÂĢ1.0m of net deferment.

 

 

Gavin Rochussen, Chief Executive, commented:

 

"AuM increased by 15% over the quarter to 31 December and by 55% from ÂĢ12.2bn on 1 April 2020 to ÂĢ18.9bn, an increase of ÂĢ6.7bn which was made up of net inflows of ÂĢ1.4bn, an increase of ÂĢ431m due to the arrival of the Phaeacian team, a reduction due to a fund closure of ÂĢ301m, and market movement and fund performance added ÂĢ5.2bn.

 

"We are pleased to report another quarter of net inflows. Net inflows from 18 of our funds amounted to ÂĢ556m in the quarter which brings total net inflows, from continuing funds, in the nine months of the current financial year to ÂĢ1.4bn.

 

"While net inflows have been particularly strong into our Technology and Healthcare funds, we have also had net subscriptions in the quarter into the Global Insurance Fund of ÂĢ234m, ÂĢ100m into our Emerging Markets Stars Fund and ÂĢ90m into our UK Value Opportunities Fund as risk appetite for UK companies increased.

 

"The pipeline for flows into our Emerging Markets Stars range of funds, which have sustainability at the core of their processes, is strong as the funds approach their three-year track records at Polar Capital.

 

"The International Value franchise within Phaeacian Partners announced in October, has made a good start within Polar outperforming benchmark over the calendar year by 8% and receiving early inflows into the US Mutual Fund.

 

"It is pleasing that following the successful restructuring of the Polar Capital Global Financials Trust last year, performance has been compelling, the Trust has been trading at a premium and issuing shares. This follows a marked improvement in investor appetite for equities in the Financials sector.

 

"Fund performance has been strong across the majority of our funds with 81% of our AuM performing ahead of benchmark over the calendar year and 83% of our AuM is ranked in the first quartile against peers over three years in the Lipper universe.

 

"Performance fee profits net of staff allocations amounted to ÂĢ19.3m compared to ÂĢ8.8m in the prior year. Given the strong performance across most of our funds, 15 funds earned performance fees and seven individual funds contributed the majority of the net performance fee profits.

 

"In December, we announced the acquisition of Dalton Strategic Partnership LLP which, once regulatory approval has been received, will contribute to our 'growth with diversification strategy' by adding, amongst a number of funds, a top performing European equities team as well as increased distribution capability into Continental Europe.

 

"We remain confident that with our diverse range of funds and focus on performance in our actively managed complementary funds we are positioned to continue to perform well for our clients and will continue to generate net inflows. The net inflow momentum of the last quarter has continued into the first two weeks of January."

 

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)

John Mansell (Executive Director)

Samir Ayub (Finance Director)

 

+44 (0)20 7227 2700

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Rishi Shah

 

+44 (0)20 3597 8680

 

Camarco

Ed Gascoigne-Pees

Georgia Edmonds

Monique Perks

 

+44 (0)20 3757 4995

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAFFDFAFFEAA
Date   Source Headline
1st Jul 202111:07 amRNSDividend Declaration
1st Jul 202110:26 amRNSDirector Declaration
1st Jul 20217:00 amRNSGroup Audited Results for year ended 31 March 2021
29th Jun 20213:53 pmRNSForm 8.3 - Ultra Electronics Holdings PLC
7th Jun 20217:00 amRNSNotice of Results
1st Jun 20217:00 amRNSTotal Voting Rights
26th May 20215:35 pmRNSDirector/PDMR Shareholding
21st May 20212:21 pmRNSDirector/PDMR Shareholding
20th May 202111:36 amRNSIssue of Equity
20th May 202110:38 amRNSHolding(s) in Company
19th May 20217:00 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
17th May 202112:45 pmRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSIssue of Equity
16th Apr 20217:00 amRNSDirector/PDMR Shareholding
15th Apr 20217:00 amRNSAuM Update
13th Apr 20214:27 pmRNSHolding(s) in Company
1st Apr 202110:44 amRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights
25th Mar 20215:45 pmRNSHolding(s) in Company
18th Mar 20214:08 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSCompletion of Dalton SP LLP Acquisition
26th Feb 20214:33 pmRNSDirector/PDMR Shareholding
26th Feb 20214:32 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSIssue of Equity
1st Feb 20215:35 pmRNSIssue of Equity
1st Feb 20217:00 amRNSBlock listing Interim Review
1st Feb 20217:00 amRNSTotal Voting Rights
25th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSIssue of Equity
20th Jan 20215:25 pmRNSDirector/PDMR Shareholding
20th Jan 20215:22 pmRNSIssue of Equity
19th Jan 20219:39 amRNSIssue of Equity
18th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Jan 20217:00 amRNSIssue of Equity
14th Jan 20217:00 amRNSAuM Update
17th Dec 20207:00 amRNSAcquisition of Dalton Strategic Partnership LLP
4th Dec 202010:08 amRNSIssue of Equity
1st Dec 20207:00 amRNSTotal Voting Rights
25th Nov 20203:36 pmRNSIssue of Equity
19th Nov 20207:00 amRNSUnaudited interim results
16th Nov 20202:13 pmRNSForm 8.3 - CPL RESOURCES PLC
2nd Nov 20208:51 amRNSTotal Voting Rights
23rd Oct 20204:26 pmRNSNotice of Results
19th Oct 20207:00 amRNSTeam Acquisition Completion
8th Oct 20204:48 pmRNSIssue of Equity
8th Oct 20207:00 amRNSAuM Update
29th Sep 202012:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.